Procyon Corp financial data

Symbol
PCYN on OTC
Industry
Pharmaceutical Preparations
Location
1300 S Highland Ave, Clearwater, FL
State of incorporation
CO
Fiscal year end
June 30
Latest financial report
10-Q - Q1 2024 - May 24, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 343 % -19.9%
Quick Ratio 79.5 % -31.8%
Debt-to-equity 36.7 % -2.34%
Return On Equity -15.2 % -192%
Return On Assets -11.1 % -194%
Operating Margin -5.11 % -19.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.11M shares +0.26%
Common Stock, Shares, Outstanding 8.11M shares
Entity Public Float 1.14M USD -17.1%
Common Stock, Value, Issued 4.45M USD +0.12%
Weighted Average Number of Shares Outstanding, Basic 8.11M shares +0.26%
Weighted Average Number of Shares Outstanding, Diluted 8.11M shares +0.26%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 4.77M USD +1.71%
Operating Income (Loss) -244K USD -21.4%
Nonoperating Income (Expense) 57.8K USD +210%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -186K USD -2.1%
Income Tax Expense (Benefit) 186K USD
Net Income (Loss) Attributable to Parent -372K USD -171%
Earnings Per Share, Basic -0.06 USD/shares -500%
Earnings Per Share, Diluted -0.06 USD/shares -500%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 482K USD -6.04%
Inventory, Net 535K USD -2.53%
Assets, Current 2.29M USD -4.48%
Deferred Income Tax Assets, Net 0 USD -100%
Property, Plant and Equipment, Net 281K USD +92.2%
Operating Lease, Right-of-Use Asset 386K USD -32.3%
Assets 3.25M USD -10.5%
Accounts Payable, Current 208K USD +0.17%
Liabilities, Current 791K USD +20.9%
Deferred Income Tax Liabilities, Net 21.4K USD
Operating Lease, Liability, Noncurrent 185K USD -49%
Liabilities 997K USD -2.01%
Retained Earnings (Accumulated Deficit) -2.37M USD -18.6%
Stockholders' Equity Attributable to Parent 2.25M USD -13.8%
Liabilities and Equity 3.25M USD -10.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 4.59K USD
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities -53.4K USD -663%
Common Stock, Shares Authorized 80M shares 0%
Common Stock, Shares, Issued 8.11M shares +0.26%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -48.8K USD +72.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 229K USD
Deferred Tax Assets, Gross 348K USD +0.77%
Operating Lease, Liability 364K USD -31.6%
Depreciation 19.2K USD +75.5%
Payments to Acquire Property, Plant, and Equipment 53.4K USD +663%
Property, Plant and Equipment, Gross 607K USD +42.2%
Operating Lease, Liability, Current 179K USD +5.73%
Lessee, Operating Lease, Liability, to be Paid, Year Two 188K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 185K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 141K USD
Deferred Tax Assets, Operating Loss Carryforwards 229K USD +20.8%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -7.76K USD -295%
Preferred Stock, Shares Authorized 496M shares 0%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 359K USD
Additional Paid in Capital 41.1K USD +15.5%
Current State and Local Tax Expense (Benefit) 0 USD
Current Federal Tax Expense (Benefit) 0 USD
Share-based Payment Arrangement, Expense 10.7K USD
Deferred State and Local Income Tax Expense (Benefit) -1.61K USD -296%